drugset / Trial / NCT01522248

Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

NCT01522248

RandomizedSingle-groupOpen-labelBasic science

Summary

Some people experience symptoms just after receiving the seasonal inactivated influenza vaccine. The cause of some of these symptoms is likely to be an immune response to the vaccine. The investigators would like to look at the earliest immune responses to the inactivated influenza vaccine. This pilot study will help us to determine at what time points we should look.

Timeline

Start
2012-01
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Influenza Virus Vaccine Vaccine 0.5 ml Intramuscular

Indications

No indication recorded.